Feasibility and Effect of Aerobic Exercise for Lowering Depressive Symptoms Among Individuals With Traumatic Brain Injury

2012 ◽  
Vol 27 (2) ◽  
pp. 99-103 ◽  
Author(s):  
Marika Schwandt ◽  
Jocelyn E. Harris ◽  
Scott Thomas ◽  
Michelle Keightley ◽  
Abe Snaiderman ◽  
...  
Brain Injury ◽  
2021 ◽  
pp. 1-8
Author(s):  
Kan Ding ◽  
Takashi Tarumi ◽  
Tsubasa Tomoto ◽  
Kathleen R. Bell ◽  
Christopher Madden ◽  
...  

Author(s):  
Simi Prakash K. ◽  
Rajakumari P. Reddy ◽  
Anna R. Mathulla ◽  
Jamuna Rajeswaran ◽  
Dhaval P. Shukla

AbstractTraumatic brain injury (TBI) is associated with a wide range of physiological, behavioral, emotional, and cognitive sequelae. Litigation status is one of the many factors that has an impact on recovery. The aim of this study was to compare executive functions, postconcussion, and depressive symptoms in TBI patients with and without litigation. A sample of 30 patients with TBI, 15 patients with litigation (medicolegal case [MLC]), and 15 without litigation (non-MLC) was assessed. The tools used were sociodemographic and clinical proforma, executive function tests, Rivermead Post-Concussion Symptom Questionnaire, and Beck Depression Inventory. Assessment revealed that more than 50% of patients showed deficits in category fluency, set shifting, and concept formation. The MLC group showed significant impairment on verbal working memory in comparison to the non-MLC group. The performance of both groups was comparable on tests of semantic fluency, visuospatial working memory, concept formation, set shifting, planning, and response inhibition. The MLC group showed more verbal working memory deficits in the absence of significant postconcussion and depressive symptoms on self-report measures.


2015 ◽  
Vol 96 (10) ◽  
pp. e105
Author(s):  
Benjamin Douglas Eschler ◽  
Asha K. Vas ◽  
Molly Keebler ◽  
Sandi Chapman ◽  
Kay Moolenijzer

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Tsubasa Tomoto ◽  
Tran Le ◽  
Takashi Tarumi ◽  
Marisara Dieppa ◽  
Kathleen Bell ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-3
Author(s):  
Reiji Yoshimura ◽  
Naomichi Okamoto ◽  
Yuki Konishi ◽  
Atsuko Ikenouchi

We present a case of panic disorder induced by the coronavirus disease (COVID-19) pandemic in a patient with an organic mood disorder. The patient was a 62-year-old woman with mild mood swings and reduced motivation and volition caused by a traumatic brain injury after a traffic accident. She was maintained on carbamazepine (600 mg/day). When the COVID-19 outbreak occurred in Japan, she developed concerns regarding the illness and complained of multiple episodes of panic attacks. Further, her depressive symptoms worsened. Thus, vortioxetine was added to the ongoing CBZ treatment. Four weeks after initiating vortioxetine treatment, the symptoms of panic disorder and depressive state were ameliorated. The present case suggests that vortioxetine augmentation can improve symptoms of depressive state and panic disorder induced by the COVID-19 pandemic.


2014 ◽  
Vol 93 (8) ◽  
pp. 687-702 ◽  
Author(s):  
Raj G. Kumar ◽  
Michael B. Bracken ◽  
Allison N. Clark ◽  
Todd G. Nick ◽  
Maria S. Melguizo ◽  
...  

2017 ◽  
Vol 32 (3) ◽  
pp. E49-E56 ◽  
Author(s):  
Ali A. Weinstein ◽  
Lisa M. K. Chin ◽  
John Collins ◽  
Divya Goel ◽  
Randall E. Keyser ◽  
...  

2020 ◽  
Vol 101 (11) ◽  
pp. e33-e34
Author(s):  
Chung Lin (Novelle) Kew ◽  
Shannon Juengst ◽  
Kathleen Bell ◽  
Kan Ding ◽  
Rong Zhang ◽  
...  

2012 ◽  
Vol 18 (5) ◽  
pp. 917-926 ◽  
Author(s):  
Diane Swick ◽  
Nikki Honzel ◽  
Jary Larsen ◽  
Victoria Ashley ◽  
Timothy Justus

AbstractCombat veterans with post-traumatic stress disorder (PTSD) can show impairments in executive control and increases in impulsivity. The current study examined the effects of PTSD on motor response inhibition, a key cognitive control function. A Go/NoGo task was administered to veterans with a diagnosis of PTSD based on semi-structured clinical interview using DSM-IV criteria (n= 40) and age-matched control veterans (n= 33). Participants also completed questionnaires to assess self-reported levels of PTSD and depressive symptoms. Performance measures from the patients (error rates and reaction times) were compared to those from controls. PTSD patients showed a significant deficit in response inhibition, committing more errors on NoGo trials than controls. Higher levels of PTSD and depressive symptoms were associated with higher error rates. Of the three symptom clusters, re-experiencing was the strongest predictor of performance. Because the co-morbidity of mild traumatic brain injury (mTBI) and PTSD was high in this population, secondary analyses compared veterans with PTSD+mTBI (n= 30) to veterans with PTSD only (n= 10). Although preliminary, results indicated the two patient groups did not differ on any measure (p> .88). Since cognitive impairments could hinder the effectiveness of standard PTSD therapies, incorporating treatments that strengthen executive functions might be considered in the future. (JINS, 2012,18, 1–10)


Sign in / Sign up

Export Citation Format

Share Document